Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,480 | 16,140 | 17,750 | 20,590 | 22,540 |
| Marketable Securities | 0 | 0 | 1,490 | 1,490 | 4,660 |
| Other current assets | 770 | 0 | -1,490 | 450 | 220 |
| TOTAL | $12,250 | $16,140 | $17,750 | $22,530 | $27,420 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4,880 | 1,890 | 1,930 | 1,970 | 2,010 |
| TOTAL | $4,880 | $1,890 | $1,930 | $1,970 | $2,010 |
| Total Assets | $17,460 | $25,670 | $27,430 | $31,770 | $36,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 590 | 530 | 1,130 | 370 | 370 |
| Accrued Expenses | 2,310 | 1,560 | 1,270 | 1,280 | 1,550 |
| TOTAL | $3,170 | $2,360 | $2,700 | $1,920 | $2,210 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,830 | 3,880 | 3,900 | 4,000 | 4,050 |
| TOTAL | $3,830 | $3,880 | $3,900 | $4,000 | $4,050 |
| Total Liabilities | $7,010 | $6,250 | $6,600 | $5,920 | $6,260 |
| Shareholders' Equity | |||||
| Common Shares | 680 | 680 | 610 | 610 | 600 |
| Retained earnings | -248,480 | -239,500 | -234,300 | -228,900 | -224,200 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 10 |
| TOTAL | $10,440 | $19,420 | $20,820 | $25,850 | $30,480 |
| Total Liabilities And Equity | $17,450 | $25,670 | $27,420 | $31,770 | $36,740 |